Clinical Trial Update: Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating cellular immunotherapy for high-risk B-cell acute lymphoblastic leukemia, with status listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia

Snippet

Sponsor: City of Hope Medical Center | Conditions: B Acute Lymphoblastic Leukemia, Recurrent Acute Lymphoblastic Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING